Barclays’s KalVista Pharmaceuticals KALV Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q3 | $7.04M | Buy |
|
|||||
|
2025
Q2 | $1.91M | Buy |
|
|||||
|
2025
Q1 | $638K | Sell |
|
|||||
|
2024
Q4 | $577K | Buy |
|
|||||
|
2024
Q3 | $778K | Buy |
|
|||||
|
2024
Q2 | $152K | Sell |
|
|||||
|
2024
Q1 | $260K | Sell |
|
|||||
|
2023
Q4 | $521K | Buy |
|
|||||
|
2023
Q3 | $40K | Sell |
|
|||||
|
2023
Q2 | $44K | Sell |
|
|||||
|
2023
Q1 | $97K | Buy |
|
|||||
|
2022
Q4 | $45K | Buy |
|
|||||
|
2022
Q3 | $38K | Buy |
|
|||||
|
2022
Q2 | $19K | Sell |
|
|||||
|
2022
Q1 | $54K | Sell |
|
|||||
|
2021
Q4 | $383K | Buy |
|
|||||
|
2021
Q3 | $181K | Buy |
|
|||||
|
2021
Q2 | $122K | Sell |
|
|||||
|
2021
Q1 | $854K | Buy |
|
|||||
|
2020
Q4 | $260K | Sell |
|
|||||
|
2020
Q3 | $185K | Buy |
|
|||||
|
2020
Q2 | $169K | Buy |
|
|||||
|
2020
Q1 | $82K | Sell |
|
|||||
|
2019
Q4 | $444K | Buy |
|
|||||
|
2019
Q3 | $209K | Sell |
|
|||||
|
2019
Q2 | $510K | Sell |
|
|||||
|
2019
Q1 | $930K | Sell |
|
|||||
|
2018
Q4 | $1.24M | Buy |
|
|||||
|
2018
Q3 | $2K | Buy |
|
|||||
|
2018
Q1 | – | Sell |
|
|||||
|
2017
Q4 | $13K | Buy |
|
|||||
|
2016
Q3 | – | Sell |
|
|||||
|
2016
Q2 | $0 | Buy |
|
|||||
|
2015
Q4 | – | Sell |
|
|||||
|
2015
Q3 | $0 | Sell |
|
|||||
|
2015
Q2 | $2K | Buy |
|